Search for: "ACTAVIS LABORATORIES FL, INC. v. US " Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Judge Sleet Finds that Actavis’ Proposed ANDA Products Infringe Recro’s Asserted Patents
27 Feb 2017, 11:16 am by Gregory B. Williams
Actavis Laboratories FL, Inc., Civil Action No. 14-1118-GMS (D.Del. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
“Substantially Equivalent” Disclosure Satisfies Written Description
15 Aug 2019, 11:16 am by Dennis Crouch
Actavis Laboratories FL, Inc. [read post]
Patently-O - http://patentlyo.com/patent
Around the IP Blogs
19 Aug 2019, 9:20 am
Actavis Laboratories FL, Inc. [read post]
IPKat - http://ipkitten.blogspot.com/
Federal Circuit Contrives Substantially Similar Written Description Test
27 Aug 2019, 2:03 am by Courtenay C. Brinckerhoff
Reddy’s Laboratories Inc., which seemed to impose a higher standard for satisfying the written description requirement, the Federal Circuit decision in Nalpropion Pharmaceuticals, Inc. v. [read post]
PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents
Federal Circuit Highlights the Importance of Separating Claim Construction and Infringement Analysis When Dealing with After-Arising Technology
28 Jan 2025, 10:24 am by Brandon Buck
Actavis Laboratories FL, Inc., 934 F.3d 1344 (Fed. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/